ATE466013T1 - Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung - Google Patents
Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellungInfo
- Publication number
- ATE466013T1 ATE466013T1 AT05808482T AT05808482T ATE466013T1 AT E466013 T1 ATE466013 T1 AT E466013T1 AT 05808482 T AT05808482 T AT 05808482T AT 05808482 T AT05808482 T AT 05808482T AT E466013 T1 ATE466013 T1 AT E466013T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- pyrroloä3
- cüpyridine
- production
- pharmaceutically acceptable
- Prior art date
Links
- SRSKXJVMVSSSHB-UHFFFAOYSA-N 1h-pyrrolo[3,2-c]pyridine Chemical class N1=CC=C2NC=CC2=C1 SRSKXJVMVSSSHB-UHFFFAOYSA-N 0.000 abstract 2
- 102100021904 Potassium-transporting ATPase alpha chain 1 Human genes 0.000 abstract 2
- 108010083204 Proton Pumps Proteins 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20040070534 | 2004-09-03 | ||
| PCT/KR2005/002925 WO2006025715A1 (en) | 2004-09-03 | 2005-09-03 | Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE466013T1 true ATE466013T1 (de) | 2010-05-15 |
Family
ID=36000317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05808482T ATE466013T1 (de) | 2004-09-03 | 2005-09-03 | Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7541366B2 (de) |
| EP (1) | EP1805177B9 (de) |
| JP (1) | JP4989477B2 (de) |
| KR (1) | KR100946220B1 (de) |
| CN (1) | CN100564379C (de) |
| AT (1) | ATE466013T1 (de) |
| AU (1) | AU2005280739B2 (de) |
| BR (1) | BRPI0514907A (de) |
| CA (1) | CA2579083C (de) |
| DE (1) | DE602005020957D1 (de) |
| DK (1) | DK1805177T3 (de) |
| ES (1) | ES2342478T3 (de) |
| MX (1) | MX2007002076A (de) |
| RU (1) | RU2375359C2 (de) |
| WO (1) | WO2006025715A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2012000275A (es) | 2009-07-09 | 2012-02-08 | Raqualia Pharma Inc | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. |
| WO2017015267A1 (en) * | 2015-07-20 | 2017-01-26 | Genzyme Corporation | Colony stimulating factor-1 receptor (csf-1r) inhibitors |
| IL293839A (en) * | 2019-12-17 | 2022-08-01 | Univ Rockefeller | enl/af9 yeats driven |
| JP2024500919A (ja) | 2020-12-23 | 2024-01-10 | ジェンザイム・コーポレーション | 重水素化コロニー刺激因子－１受容体（ｃｓｆ－１ｒ）阻害剤 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3269604D1 (en) * | 1981-06-26 | 1986-04-10 | Schering Corp | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
| JP3465827B2 (ja) * | 1993-02-24 | 2003-11-10 | 株式会社日清製粉グループ本社 | アザインドール誘導体およびこれを有効成分とする抗潰瘍薬 |
| US5451566A (en) * | 1993-11-17 | 1995-09-19 | Zeneca Limited | Herbicidal pyrrolopyridine compounds |
| DE69529056T2 (de) * | 1994-01-19 | 2003-11-13 | Sankyo Co., Ltd. | Pyrrolopyridazin-derivate |
| SE9704404D0 (sv) * | 1997-11-28 | 1997-11-28 | Astra Ab | New compounds |
| US20040110785A1 (en) * | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| FR2822463B1 (fr) | 2001-03-21 | 2004-07-30 | Lipha | Derives bicycliques de guanidines et leurs applications en therapeutique |
| US7361671B2 (en) | 2001-11-15 | 2008-04-22 | The Institute For Pharmaceutical Discovery, Inc. | Substituted heteroarylalkanoic acids |
| TW200301251A (en) | 2001-12-20 | 2003-07-01 | Wyeth Corp | Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
-
2005
- 2005-09-03 JP JP2007529715A patent/JP4989477B2/ja not_active Expired - Fee Related
- 2005-09-03 DK DK05808482.3T patent/DK1805177T3/da active
- 2005-09-03 CA CA2579083A patent/CA2579083C/en not_active Expired - Fee Related
- 2005-09-03 ES ES05808482T patent/ES2342478T3/es not_active Expired - Lifetime
- 2005-09-03 RU RU2007112111/04A patent/RU2375359C2/ru not_active IP Right Cessation
- 2005-09-03 MX MX2007002076A patent/MX2007002076A/es active IP Right Grant
- 2005-09-03 CN CNB2005800293815A patent/CN100564379C/zh not_active Expired - Fee Related
- 2005-09-03 KR KR1020050082009A patent/KR100946220B1/ko not_active Expired - Fee Related
- 2005-09-03 WO PCT/KR2005/002925 patent/WO2006025715A1/en not_active Ceased
- 2005-09-03 DE DE602005020957T patent/DE602005020957D1/de not_active Expired - Lifetime
- 2005-09-03 US US11/574,406 patent/US7541366B2/en not_active Expired - Fee Related
- 2005-09-03 BR BRPI0514907-0A patent/BRPI0514907A/pt not_active Application Discontinuation
- 2005-09-03 AU AU2005280739A patent/AU2005280739B2/en not_active Ceased
- 2005-09-03 AT AT05808482T patent/ATE466013T1/de not_active IP Right Cessation
- 2005-09-03 EP EP05808482A patent/EP1805177B9/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2579083A1 (en) | 2006-03-09 |
| WO2006025715A1 (en) | 2006-03-09 |
| JP4989477B2 (ja) | 2012-08-01 |
| CN101010322A (zh) | 2007-08-01 |
| EP1805177B9 (de) | 2010-09-15 |
| EP1805177A1 (de) | 2007-07-11 |
| EP1805177B1 (de) | 2010-04-28 |
| AU2005280739A1 (en) | 2006-03-09 |
| DK1805177T3 (da) | 2010-08-02 |
| RU2007112111A (ru) | 2008-10-10 |
| US7541366B2 (en) | 2009-06-02 |
| CA2579083C (en) | 2011-06-14 |
| EP1805177A4 (de) | 2009-07-29 |
| HK1105978A1 (en) | 2008-02-29 |
| KR100946220B1 (ko) | 2010-03-08 |
| AU2005280739B2 (en) | 2010-11-11 |
| DE602005020957D1 (de) | 2010-06-10 |
| KR20060051003A (ko) | 2006-05-19 |
| BRPI0514907A (pt) | 2008-06-24 |
| JP2008511619A (ja) | 2008-04-17 |
| CN100564379C (zh) | 2009-12-02 |
| MX2007002076A (es) | 2007-03-29 |
| RU2375359C2 (ru) | 2009-12-10 |
| US20070249658A1 (en) | 2007-10-25 |
| ES2342478T3 (es) | 2010-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE533765T1 (de) | Pyrroloä2,3-cüpyridinderivate und verfahren für deren herstellung | |
| NO20063231L (no) | Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer | |
| ATE365742T1 (de) | 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren | |
| MEP23808A (en) | Pyridine[3,4-b]pyrazinones | |
| WO2006010546A3 (en) | Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors | |
| WO2009115517A3 (en) | Pyridines and pyrazines as inhibitors of pi3k | |
| WO2005051906A3 (en) | Heterocyclic inhibitors of mek and methods of use thereof | |
| WO2007120647A3 (en) | Compositions useful as inhibitors of voltage-gated sodium channels | |
| NO20070445L (no) | Pyrimidinderivater. | |
| WO2006126082A3 (en) | Pyridine [3,4-b] pyrazinones as pde-5 inhibitors | |
| WO2005037825A3 (en) | Protein kinase inhibitors | |
| WO2005042497A3 (en) | Benzimidazoles useful as modulators of ion channels | |
| WO2006011050A3 (en) | Pyridine derivatives | |
| NO20064077L (no) | Kemokinreseptorantagonister | |
| NO20073551L (no) | Nikotinacetylkolinreseptorligander | |
| AP1564A (en) | Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use. | |
| WO2006065590A3 (en) | Pyridine and pyrimidine antiviral compositions | |
| WO2006116733A3 (en) | Protein kinase inhibitors | |
| EP1784402A4 (de) | PYRROLO[3,2-c]PYRIDINDERIVATE UND HERSTELLUNGSVERFAHREN DAFÜR | |
| ATE466013T1 (de) | Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung | |
| EP1219296A4 (de) | Mittel zur hemmung der sebumproduktion | |
| WO2006072000A3 (en) | Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto | |
| WO2006124865A3 (en) | Biaryls derivatives useful as modulators of ion channels | |
| NO20055749L (no) | Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer | |
| NO20073547L (no) | Nikotinacetykolinreseptorligander |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |